MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine TherapyGeorge W. Sledge, Antonio Llombart‐Cussac, Kenichi Inoue et al.|Journal of Clinical Oncology|2017Cited by 1.7k
Data-analysis strategies for image-based cell profilingJuan Carlos Caicedo, Anne E. Carpenter, Sam Cooper et al.|Nature Methods|2017Cited by 789